Countries Hongkong

Antengene's ATG-022 Receives Orphan Drug Designations for Gastric and Pancreatic Cancers

Orphan Drugs, also known as Rare Disease Drugs, refers to pharmaceutical products developed for the prevention, diagnosis, and treatment of rare diseases o...

 May 24, 2023 | News

Antengene Clears U.S. IND for Phase I Trial of ATG-031 Antibody

-  ATG-031, discovered and developed in-house by Antengene, is the world's first anti-CD24 antibody to advance to the clinic in oncolog...

 May 18, 2023 | News

Sirnaomics to Receive HK$8M Subsidy for Clinical Translational Catalyst Plan

The subsidy comes under HKSTP's Clinical Translational Catalyst ("CTC") programme dedicated to catalysing clinical translation to bring innovative, life-ch...

 May 18, 2023 | News

Antengene Announces NDA Submission for XPOVIO® in Indonesia

"In just six months, we have submitted NDAs for XPOVIO® in three ASEAN countries, Malaysia, Thailand and Indonesia, supporting...

 May 17, 2023 | News

International Healthcare Week returns to showcase Hong Kong's strengths in healthcare innovation and investment

The second International Healthcare Week (IHW), organised by the Hong Kong Trade Development Council (HKTDC) and supported by a wide range of healthcare se...

 May 04, 2023 | News

Agilis Robotics tests animal trial for GI indication, aims 510(k) clearance by 2025 for improved endoscopic surgery.

The system by Agilis Robotics offers a novel combination of features that set it apart from conventional surgical robotic systems. With a remarkably compac...

 April 19, 2023 | News

HUTCHMED's Fruquintinib NDA Accepted in China for 2nd-Line Gastric Cancer

Dr. Michael Shi, Head of R&D and Chief Medical Officer of HUTCHMED said, “The NMPA acceptance of our NDA for fruquintinib is a positive step towa...

 April 18, 2023 | News

Sirnaomics Launches Phase I Clinical Trial for GalNAc Factor XI Program

Sirnaomics Ltd. (the "Company", Stock Code: 2257.HK, together with its subsidiaries, the "Group" or "Sirnaomics"), a leading bioph...

 April 13, 2023 | News

BGI Global's Colorectal Cancer Survey uncovers gaps in awareness and concerns over affordability

This inaugural report seeks to better understand the global state of CRC awareness, as well as attitudes and actions towards CRC screening for average risk...

 April 07, 2023 | News

Rxilient Biotech and Junshi Biosciences form Joint Venture to develop and commercialize Toripalimab in Southeast Asia

  Toripalimab is an anti-PD-1 monoclonal antibody independently developed by Junshi Biosciences. Junshi Biosciences has conducted over 30 clinical tr...

 March 31, 2023 | News

Antengene Doses First Patient with ATG-022 for Advanced Solid Tumors in Australia

Discovered and developed in-house by Antengene's R&D team, ATG-022 is an antibody-drug-conjugate (ADC) targeting the Tumor Associated Antig...

 March 29, 2023 | News

Asians Prioritize Health Span to Boost Retirement Well-being, Reveals Manulife Survey

Survey of 7,000+ people in Asia shows expectation of early retirement, early deterioration in health Concerns about cost of well-being nu...

 March 29, 2023 | News

Boan Biotech Announces 2022 Financial Results

Boan Biotech (6955.HK) today announced its 2022 financial results and recent business developments. 2022 business highlights Record high in revenue: In...

 March 28, 2023 | News

'Generations Connect' Project aims to help boost the well-being of 10,000 elderly

e-Health Literacy is closely related to the health and well-being of the elderly. Sino Group and the Ng Teng Fong Charitable Foundation, in collaboration w...

 March 25, 2023 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in